AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Monoclonal Antibodies Against Tumor Necrosis Factor (TNF-α; 3 lines)

Detailed Technology Description
Applications Tumor necrosis factor is a cell signaling protein orcytokine that is involved in inflammation, and specifically one of the proteinsin the acute phase reaction. TNF is produced mainly by macrophages but otherwhite cells too. Some of its roles are to induce fever, apoptotic cell death,inhibit tumorigenesis and inflammation. Diseases associated with dysregulationof TNF production include inflammatory bowel disease (IBD), Psoriasis,Alzheimer's and cancer. Validated for use in WB and ELISA. Some cross-reactivity observed with rHTNFα.  None with nETNFß, nMTNFα, rMTNFß and rPTNFα
*Abstract

ReagentDescription           

Antigen: 

TNF

Line name (Isotype)

6H4.E1 (IgG2b);  9B10 (IgG2b); 12F6 (IgG1)

Reactivity: 

Equine, related species

Immunogen: 

Protein

Species Immunized: 

Mouse

Buffer: 

0.1M Sodium Phosphate, pH 7.4, 0.15M NaCl, 0.05% (w/v) Sodium Azide

Tested Applications: 

ELISA, WB, IP, Competitive ELISA

 .

References

 

SuX, Morris DD, Crowe NA, Moore JN, Fischer KJ, McGraw RA. Equine tumor necrosisfactor alpha: cloning and expression in Escherichia coli, generation ofmonoclonal antibodies, and development of a sensitive enzyme-linkedimmunosorbent assay. Hybridoma. 1992Dec. 11(6):715-27

Country/Region
USA

For more information, please click Here
Mobile Device